
After much speculation, Donald Trump recently announced his top pick for Commissioner of the FDA as Dr Scott Gottlieb. Gottlieb …

Mylan’s plan to bring its generic competitor to GSK’s best-selling respiratory drug, Advair, has hit a major snag after it …

In big news for sufferers of MS and the company that developed the drug, Roche subsidiary Genetech, the FDA has …

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …

A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …

If most people were asked whether they had heard of a scandal in the pharmaceutical industry, the drug that would …

A team of researchers at the University of California, San Diego (UCSD) have developed a drug therapy which has shown …

Regeneron and Sanofi have received approval for its eczema treatment, Dupixent, by the FDA. The treatment will be the first …

NHS England has identified 10 items that it believes can cut £128 million from its yearly bill. The 10 items …

Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …
Kite Pharma has revealed the addition of celebrated bioscientist and researcher Dr Owen N. Witte to its Board of Directors, …

Mylan continues to cut away Meda’s US operations to “reduce redundancy” – the latest sees Mylan closing an Illinois-based facility, …

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to …

The research organisation ABPI, alongside RAND Europe, has released a ‘snapshot’ of data, from its Disclosure UK database, from January …
Leading UK contract analytical chemistry provider, Butterworth Laboratories Ltd, is delighted to announce it has secured an additional facility in …

Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is …

Bone Therapeutics, a bone cell therapy company focusing on orthopaedics and bone disease, has appointed Miguel Forte to the position …

Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given …